Evidence-Based Medicine Guidelines
Combination of doxazosin and finasteride compared with either drug alone or placebo for benign prostatic hyperplasia
Combination of doxazosin and finasteride compared with either drug alone or placebo for benign prostatic hyperplasia is a topic covered in the Evidence-Based Medicine Guidelines.
To view the entire topic, please log in or purchase a subscription.
Evidence Central is an integrated web and mobile solution that helps clinicians quickly answer etiology, diagnosis, treatment, and prognosis questions using the latest evidence-based research. Explore these free sample topics:
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Combination of Doxazosin and Finasteride Compared With Either Drug Alone or Placebo for Benign Prostatic Hyperplasia." Evidence-Based Medicine Guidelines, Duodecim Medical Publications Limited, 2019. Evidence Central, evidence.unboundmedicine.com/evidence/view/EBMG/455629/all/Combination_of_doxazosin_and_finasteride_compared_with_either_drug_alone_or_placebo_for_benign_prostatic_hyperplasia.
Combination of doxazosin and finasteride compared with either drug alone or placebo for benign prostatic hyperplasia. Evidence-Based Medicine Guidelines. Duodecim Medical Publications Limited; 2019. https://evidence.unboundmedicine.com/evidence/view/EBMG/455629/all/Combination_of_doxazosin_and_finasteride_compared_with_either_drug_alone_or_placebo_for_benign_prostatic_hyperplasia. Accessed September 26, 2022.
Combination of doxazosin and finasteride compared with either drug alone or placebo for benign prostatic hyperplasia. (2019). In Evidence-Based Medicine Guidelines. Duodecim Medical Publications Limited. https://evidence.unboundmedicine.com/evidence/view/EBMG/455629/all/Combination_of_doxazosin_and_finasteride_compared_with_either_drug_alone_or_placebo_for_benign_prostatic_hyperplasia
Combination of Doxazosin and Finasteride Compared With Either Drug Alone or Placebo for Benign Prostatic Hyperplasia [Internet]. In: Evidence-Based Medicine Guidelines. Duodecim Medical Publications Limited; 2019. [cited 2022 September 26]. Available from: https://evidence.unboundmedicine.com/evidence/view/EBMG/455629/all/Combination_of_doxazosin_and_finasteride_compared_with_either_drug_alone_or_placebo_for_benign_prostatic_hyperplasia.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Combination of doxazosin and finasteride compared with either drug alone or placebo for benign prostatic hyperplasia
ID - 455629
BT - Evidence-Based Medicine Guidelines
UR - https://evidence.unboundmedicine.com/evidence/view/EBMG/455629/all/Combination_of_doxazosin_and_finasteride_compared_with_either_drug_alone_or_placebo_for_benign_prostatic_hyperplasia
PB - Duodecim Medical Publications Limited
DB - Evidence Central
DP - Unbound Medicine
ER -
